PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban
Trial details
- Registry ID
- NCT04142658
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on ApixabanNCT04142658 | AORT | Phase 3 | Terminated | 2022-12-12Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |